We end cancer with intelligent genomics

Quantgene is revolutionizing early cancer detection, delivering a new standard for multi-cancer early detection (MCED) directly to your doorstep.

What we offer

For Patients

The patient is at the center of everything we do
Qx is a multi-cancer early detection (MCED) test that works by combining high-sensitivity genomics with imaging & medical data to identify early cancer signals from a standard blood sample.

For Hospitals

Breaking barriers to bring breakthrough diagnostics
If you're a hospital, Qi can help you establish and manage state-of-the-art genomics testing infrastructure in your premises, enabling you to offer genomics to your patients, in-house.

Quantgene Milestones

$36m

Invested in breakthrough liquid biopsy diagnostics technology*

4

Master patents filed as a result of 8 years of focused R&D

5000+

Patient samples successfully processed in early clinical trials

Hear our partners speak

“I believe Quantgene is a unique group of people with great respect for academic research and extensive knowledge of clinical science. Quantgene has been a great partner to me in my academic clinical research and very helpful in our attempt to improve cancer risk determination in high-risk populations of women”

Dr Setsuko Chambers
Chair, Ovarian Cancer Research

“Quantgene has been pioneering genomics technology at an astonishing pace. I believe the team has built something incredible that can change the future of medicine”

Co-founder,
Vikor Scientific

“It’s very rare to come across something with the scale and potential impact of Quantgene. Making genomics intelligent could be a game-changer in not only our fight against cancer but also in our fight with mental health issues, autoimmune and other diseases.”

Jamey Edwards,
Chief Operating Officer

“We use Quantgene’s genomics technology in my clinical research for early cancer detection, and I couldn’t think of a better partner. Using Genomics for early detection is one of the most promising innovation pathways to reduce cancer deaths in America.”

Dr Dan Raz,
Director, Lung & Thoracic Program

Our Mission

Quantgene’s mission is to leverage genomics and intelligence systems to protect human life. Our solutions help patients, physicians and hospitals to easily access genomics and translate findings into true patient protection and better clinical outcomes.

What makes breakthrough technology?

At Quantgene, there is no “not invented here “ syndrome. Our only goal is to end cancer by any means necessary.

For our research, that means we develop proprietary technologies and when it makes sense; integrate third party components. The result is industry-leading solutions free of vanity and special interests that are optimized to end cancer.Our breakthrough cfDNA liquid biopsy screening works by identifying early cancer signals in the blood using genomic algorithms.
Read the science